HERZLIYA, Israel and CALGARY, AB, Jan. 29, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical ...

The patent covers long-acting variants of C-Type Natriuretic Peptide (CNP). BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.) The legal action, which would result in a ...

TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, has been recognized by CIOTechOutlook as one ...

The patent covers long-acting variants of C-Type Natriuretic Peptide (CNP). BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.) The legal action, which would result in a decision in ...

Trademarks and logos are the property of their respective ... integrated contract development and manufacturing services for pharmaceutical and biotechnology customers. To learn more about how ...

Geri Care Health Services, India’s first integrated senior citizen-focused healthcare services provider today announced that ...

May River Capital, a Chicago-based lower middle-market private equity firm, today announced the merger of its portfolio companies, Advanced Material Processing ('AMP') and Automated Handling Solutions ...

Veeda Group has unveiled a new logo and brand identity—Veeda Lifesciences—reflecting ... with reputable sponsors, including leading global pharma companies.

Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class ...

Many Americans support prohibiting commercials for prescription drugs on television. But enacting that ban could be ...

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.

NORTHFIELD, Minn., Jan. 28, 2025 /PRNewswire/ -- Aurora Pharmaceutical, a leading manufacturer of animal health products, is excited to announce the appointment of Stephanie Hastings as its new ...